Molecular Diagnostics

Novel Biomarker Predicts Response to Therapy in Patients with a Rare Form of Metastatic Colorectal Cancer
Cancer researchers have identified a biomarker that predicts response of patients with microsatellite stable BRAF V600E metastatic colorectal cancer (MSS mCRC) to treatment with combined anti-BRAF/EGFR therapy. More...29 Sep 2022

CDH1 Overexpression Predicts Early-Stage Bladder Cancer
Bladder cancer (BC) is a serious public health problem, but effective biomarkers for BC diagnosis, particularly in the early stage, are still lacking. Identification of reliable biomarkers associated with early-stage BC is of great importance to early treatment and an improved outcome. More...29 Sep 2022


Mindray Launches High-Sensitivity and High-Specificity ToRCH Panel
Mindray (Shenzhen, China) has launched the ToRCH Panel that provides high-quality assays to meet different clinical needs. Thanks to the improved raw materials, processes, formulas, reaction models, and standardized traceability, Mindray ToRCH reagents deliver excellent seroconversion sensitivity. More...28 Sep 2022

Single Blood Test Predicts Risk of Multiple Diseases Simultaneously Using AI
Scientists have profiled 168 metabolic markers in the blood samples of over 100,000 people and combined this data with their medical histories. Using AI, they were able to predict the risk of onset of several diseases with just one test and show where early intervention could be beneficial. More...26 Sep 2022

Simple Blood Test Prior to CAR T-Cell Therapy Could ID Patients at Risk for Neurotoxicity
Neurologic complications are common following treatment with chimeric antigen receptor (CAR) T cells. Now, a small study has demonstrated that a simple blood test before treatment can help identify patients who may be more likely to develop neurotoxicity. More...23 Sep 2022

A Single-Cell RNA-Sequencing-Based Non-Invasive Screening Tool for Endometriosis
Results presented in a recent paper lay the ground work for using menstrual effluent (ME) as an effective screening tool for identifying endometriosis in patients with chronic symptoms suggestive of this disorder. More...21 Sep 2022
In Other News
Bioperfectus Launches New MPXV Detection Kits for Better Control of Monkeypox Virus Outbreak
New Diagnostic Tool Reads Fracture Risk in Drop of Blood
Simple Blood and Urine Test Can Help Patients with Chronic Kidney Disease
New Biomarkers to Help Gauge Response of Melanoma Patients to Immune Checkpoint Therapy
Ultima Genomics Sequencer for Single-Cell RNA-Seq Evaluated
AI-Enabled POC Device Detects Cancers Without Biopsies
Endotrophin Blood Test Can Predict Outcomes in Patients with Heart Failure
Inherited Genetic Variants Increase Risk of Hodgkin Lymphoma
Molecular Endometrial Cancer Test Developed
Portable Sample-to-Answer PCR System Enables Multiplex Real-Time Detection of 27 Targets
Simple Blood Test Can Detect Early-Stage Colorectal Cancer from Gut Bacteria
Simple Blood Test Quickly and Accurately Detects Ovarian Cancer
Blood-Based Liver Disease Test Could Replace Invasive Biopsy
MCED Tests Mark New Era of Early Cancer Detection
Metabolic Disturbances Characterize Patients with Idiopathic Intracranial Hypertension
Multiparameter Test Could Detect and Diagnose Cancer from a Milliliter of Blood
Portable, Sample to Answer PCR Device Delivers Accurate Results in 30 Minutes at Point of Need
Rapid POC Diagnostic Test for Syphilis Could Produce Results in Under 20 Minutes
African-Specific Molecular Taxonomy of Prostate Cancer Revealed
Elevated Blood Levels of Neurofilament Light Chain Predict Likelihood of Neurotoxicity Following CAR-T Immunotherapy
qPCR Assay Identifies Melanoma Patients With Low-Risk Tumor That Could Avoid Invasive Biopsy
Improved ALS Blood Test Requires Less Stringent Storage and Work Conditions
AI Algorithm Combined With Blood Test Quickly and Accurately Diagnoses Heart Attacks in Women
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








